Early Studies Suggest Omicron is Formidable — But not Unstoppable

Early studies of COVID-19 vaccine effectiveness against Omicron show that booster shots could help control the variant by raising virus-fighting antibodies high enough to block the pathogen, according to Pfizer. Early data suggests Omicron can dodge some of the most important protection provided by vaccines, but only partially. “With omicron, with these data over the past 24 hours, I’d say it’s unequivocal that boosting for the winter is important,” said Shane Crotty, an immunologist who was not involved in the studies released this week. “For the general public, the good news is the boosters are going to work, full stop.”

You will be redirected in 2 seconds.